How obesity impacts the skin microbiome - Literature review
DOI:
https://doi.org/10.12775/QS.2026.49.67179Keywords
obesity, skin microbiome, skin diseases, bacteriaAbstract
Background. Obesity is becoming an increasingly serious problem in society and affects an entire human body including skin. It potentially affects barrier integrity, immune responses and susceptibility to dermatoses.
Aim. This review aims to examine how obesity changes the composition and function of the skin microbiome and what are the possible consequences.
Material and methods. A research was performed in the PubMed and Google Scholar based on peer-reviewed studies published between 2017 – 2025 and focusing on phrases “skin microbiome”, “obesity”, and “skin diseases”.
Results. Available studies indicate reduced microbial diversity, increased colonisation by opportunistic pathogens and overgrowth of yeasts on the skin of obese patients. Mechanical factors such as friction, sweating and elevated skin-fold temperature promote dysbiosis and inflammation. These changes are associated with dermatoses such as atopic dermatitis, intertrigo, folliculitis, seborrhoeic dermatitis and hidradenitis suppurativa. Treatment strategies include weight reduction, targeted skincare, antimicrobial treatment and new microbiome-modulating therapies.
Conclusions. Obesity significantly influences the skin microbiome, contributing to a higher risk of infections and inflammatory dermatoses. Although the understanding of these mechanisms is improving, further research, particularly involving metagenomics and metabolomics is needed to develop more precise preventive and therapeutic approaches.
References
1. Salam M, Yousuf R, Salam MW, Haque M. Obesity and overweight: A global public health issue. Adv Hum Biol. 2023;13(1):154-156. https://doi.org/10.4103/aihb.aihb_106_22.
2. GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405(10481):813-838. https://doi.org/10.1016/S0140-6736(25)00355-1.
3. Blüher M. Obesity: Global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298. https://doi.org/10.1038/s41574-019-0176-8.
4. Shehata E, Parker A, Suzuki T, Swann JR, Suez J, Kroon PA, Day-Walsh P. Microbiomes in physiology: insights into 21st-century global medical challenges. Exp Physiol. 2022;107(4):257-264. https://doi.org/10.1113/EP090226.
5. Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Skin changes in the obese patient. J Am Acad Dermatol. 2019;81(5):1037-1057. https://doi.org/10.1016/j.jaad.2018.12.070.
6. Kreouzi M, Theodorakis N, Nikolaou M, Feretzakis G, Anastasiou A, Kalodanis K, Sakagianni A. Skin Microbiota: Mediator of interactions between metabolic disorders and cutaneous health and disease. Microorganisms. 2025;13(1):161. https://doi.org/10.3390/microorganisms13010161.
7. Berg G, Rybakova D, Fischer D, Cernava T, Vergès MC, Charles T, Chen X, Cocolin L, Eversole K, Corral GH, Kazou M, Kinkel L, Lange L, Lima N, Loy A, Macklin JA, Maguin E, Mauchline T, McClure R, Mitter B, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. https://doi.org/10.1186/s40168-020-00875-0.
8. Kennedy MS, Chang EB. The microbiome: Composition and locations. Prog Mol Biol Transl Sci. 2020;176:1-42. https://doi.org/10.1016/bs.pmbts.2020.08.013.
9. Ito Y, Amagai M. Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases. Inflamm Regen. 2022;42(1):26. https://doi.org/10.1186/s41232-022-00212-y.
10. Sanford JA, Gallo RL. Functions of the skin microbiota in health and disease. Semin Immunol. 2013;25(5):370-377. https://doi.org/10.1016/j.smim.2013.09.005.
11. Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143-155. https://doi.org/10.1038/nrmicro.2017.157.
12. Adamczyk K, Garncarczyk A, Antończak P. The microbiome of the skin. Dermatol Rev/Przegl Dermatol. 2018;105(2):285-297. https://doi.org/10.5114/dr.2018.75584.
13. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190-1192. https://doi.org/10.1126/science.1171700.
14. McAleer JP. Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists. Front Allergy. 2023;4:1167800. https://doi.org/10.3389/falgy.2023.1167800.
15. Kong HH, Segre JA. Skin microbiome: looking back to move forward. J Invest Dermatol. 2012;132(3 Pt 2):933-939. https://doi.org/10.1038/jid.2011.417.
16. Skoracka K, Hryhorowicz S, Schulz P, Zawada A, Ratajczak-Pawłowska AE, Rychter AM, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. The role of leptin and ghrelin in the regulation of appetite in obesity. Peptides. 2025;186:171367. https://doi.org/10.1016/j.peptides.2025.171367.
17. Ylli D, Sidhu S, Parikh T, Burman KD. Endocrine changes in obesity. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext. MDText.com, Inc.; 2022.
18. Lin LY, Hsu CY, Chao JC, Chien YN, Chiou HY. Interactive effects of sleep duration and dietary patterns on obesity moderated by age. Sci Rep. 2025;15(1):34548. https://doi.org/10.1038/s41598-025-17886-2.
19. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013;2013:139239. https://doi.org/10.1155/2013/139239.
20. Ma L, Zhang H, Jia Q, Bai T, Yang S, Wang M, Li Y, Shao L. Facial physiological characteristics and skin microbiomes changes are associated with Body Mass Index (BMI). Clin Cosmet Investig Dermatol. 2024;17:513-528. https://doi.org/10.2147/CCID.S447412.
21. Palanivel JA, Millington GWM. Obesity-induced immunological effects on the skin. Skin Health Dis. 2023;3(3):e160. https://doi.org/10.1002/ski2.160.
22. Rood KM, Buhimschi IA, Jurcisek JA, Summerfield TL, Zhao G, Ackerman WE, Wang W, Rumpf RW, Thung SF, Bakaletz LO, Buhimschi CS. Skin microbiota in obese women at risk for surgical site infection after cesarean delivery. Sci Rep. 2018;8(1):8756. https://doi.org/10.1038/s41598-018-27134-5.
23. Frasca D, Strbo N. Effects of obesity on infections with emphasis on skin infections and wound healing. J Dermatol Skin Sci. 2022;4(3):5-10. https://doi.org/10.29245/2767-5092/2022/3.1157.
24. Pera F, Suman C, Cosma M, Mazza S, Brunani A, Cancello R. Intertrigo in severe obesity: clinical insights and outcomes with a new antimicrobial silver-infused breathable fabric. J Cosmet Dermatol. 2025;24(5):e70161. https://doi.org/10.1111/jocd.70161.
25. Woolhiser E, Keime N, Patel A, Weber I, Adelman M, Dellavalle RP. Nutrition, obesity, and seborrheic dermatitis: systematic review. JMIR Dermatol. 2024;7:e50143. https://doi.org/10.2196/50143.
26. Chung MG, Preda-Naumescu A, Yusuf N. Hidradenitis suppurativa: consequences of microbiome dysbiosis on immune dysregulation and disease severity. Indian J Dermatol. 2022;67(6):699-704. https://doi.org/10.4103/ijd.ijd_623_21.
27. Seite S, Flores GE, Henley JB, Martin R, Zelenkova H, Aguilar L, Fierer N. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol. 2014;13(11):1365-1372.
28. Flint E, Ahmad N, Rowland K, Hildebolt C, Raskin D. Topical probiotics reduce atopic dermatitis severity: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. Cureus. 2024;16(9):e70001. https://doi.org/10.7759/cureus.70001.
29. Paetzold B, Willis JR, Pereira de Lima J, Knödlseder N, Brüggemann H, Quist SR, Gabaldón T, Güell M. Skin microbiome modulation induced by probiotic solutions. Microbiome. 2019;7(1):95. https://doi.org/10.1186/s40168-019-0709-3.
30. Perin B, Addetia A, Qin X. Transfer of skin microbiota between two dissimilar autologous microenvironments: a pilot study. PLoS One. 2019;14(12):e0226857. https://doi.org/10.1371/journal.pone.0226857.
31. Dinić M, Gonzalez T, Caridad Hernandez M, Radojević D, Fernandez L, Golić N, Pastar I. Postbiotics as microbial-derived therapeutics for wound healing disorders: from molecular mechanisms to future application. Cell Commun Signal. 2025;23(1):504. https://doi.org/10.1186/s12964-025-02494-4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Marta Opalińska-Kubowicz, Kinga Popieralska, Zuzanna Musialska, Yuliia Protsenko, Marta Kowalska, Magdalena Barczewska, Dominika Bieszczad, Anna Marczak, Olga Stadnicka, Marzena Swojnóg, Adam Mazurek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 24
Number of citations: 0
